Month: April 2025

– Data demonstrate that ARV-102 was well tolerated, orally bioavailable, and brain-penetrant; ARV-102 achieved central and peripheral LRRK2 reduction indicating substantial LRRK2 protein degradation in healthy volunteers – – Findings support continued evaluation of ARV-102 in neurodegenerative diseases associated with LRRK2 dysfunction; a Phase 1 trial in patients with Parkinson’s disease has been initiated and is currently enrolling – NEW HAVEN, Conn., April 04, 2025 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today presented data from the first-in-human clinical trial of ARV-102, the Company’s investigational PROteolysis TArgeting Chimera (PROTAC) leucine-rich repeat kinase 2 (LRRK2) degrader. In the...

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) — Rogers Communications Inc. (TSX: RCI.A and RCI.B; NYSE: RCI) (“Rogers”) today announced that it has commenced consent solicitations to amend the indentures governing certain of its outstanding US dollar-denominated and Canadian dollar-denominated notes, including notes originally issued by Shaw Communications Inc. (collectively the “Consent Solicitations”), as listed in the table below (the “Notes”). The Consent Solicitations are being made in connection with the subsidiary equity investment announced today by Rogers and Blackstone. Rogers intends to use substantially all of the net proceeds of the subsidiary equity investment to repay debt. The subsidiary equity investment will be reported as equity in Rogers’ consolidated financial statements, and is expected to be considered an equity...

Proceeds will be used to repay debt Expects debt leverage ratio to be reduced by 0.7x following the close of the transaction Rogers will maintain full operational control of its wireless network TORONTO, April 04, 2025 (GLOBE NEWSWIRE) — Rogers Communications Inc. (TSX: RCI.A and RCI.B; NYSE: RCI) today announced it has entered into a definitive agreement with funds managed by Blackstone, backed by leading Canadian institutional investors, for a CDN$7 billion equity investment. Under the terms of the transaction, Blackstone will acquire a non-controlling interest in a new Canadian subsidiary of Rogers that will own a minor part of Rogers wireless network. Rogers will maintain full operational control of its network and will include the financial results of the subsidiary in its consolidated financial statements. “This strategic...

SYDNEY, April 04, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), today published its monthly update for March 2025. March HighlightsOperating data center capacity increased to 660MW Bitcoin mining capacity now 37 EH/s, up from 31 EH/s On track for 50 EH/s in H1 2025 Pausing mining expansion at 52 EH/s for AI / HPC New 600MW grid connection agreement signed 2.75GW now secured for data centers in West Texas Progressing debt financing workstreamsKey Metrics Mar 25 Feb 25 Jan 25       Bitcoin Mining      Average operating hashrate 30.3 EH/s 28.7 EH/s 29.0 EH/sBitcoin mined3 533 BTC 459 BTC 521 BTCRevenue (per Bitcoin) $85,012   $95,570   $99,789  Electricity cost (per Bitcoin)1 ($20,460)   ($28,341)   ($24,683)  Revenue $45.3m $43.9m $52.0mElectricity...

Stockholm, Sweden, April 4, 2025 – Virtune, a regulated Swedish issuer of crypto Exchange Traded Products (ETPs), is proud to announce that it has renewed its EU Base Prospectus on April 4, 2025. Virtune is a regulated Swedish digital asset manager and issuer of crypto exchange traded products headquartered in Stockholm. Virtune’s vision is to become the leading crypto asset manager in the Nordics by taking on an educational role around crypto assets as an asset class, while maintaining a strong focus on transparency and investor protection. Virtune’s ETPs are currently listed on Nasdaq Stockholm, Nasdaq Helsinki, Euronext Amsterdam, Euronext Paris, and Boerse Stuttgart. Through Virtune’s products, both institutional and retail investors can gain exposure to crypto assets as easily as buying a stock. Virtune has now earned the trust of...

ÍL-sjóður has completed the write-down of its own holdings in bond series HFF150434 and HFF150644. The table below provides an overview of the nominal value outstanding before and after the reduction (all amounts are in ISK, nominal value).  HFF150434 HFF150644Outstanding nominal before reduction    171.675.325.994 269.476.440.198Nominal reduction      29.187.317.946      19.801.270.932Outstanding nominal after reduction    142.488.008.048    249.675.169.266In a stock exchange announcement dated March 11, ÍL-sjóður convened meetings of bondholders in these series, to be held on April 10th. At each meeting, a proposal will be presented to amend the terms of the bonds in the respective series. The proposal grants the issuer the authority to settle with bondholders. If approved by the required majority and exercised...

MESQUITE, NV, April 04, 2025 (GLOBE NEWSWIRE) — Mesquite, NV — Dogecoin Cash, Inc. (OTCIQ: CBDS), is pleased to announce that its subsidiary, PrestoDoctor (www.prestodoctor.com), is rolling out a limited-time April promotion offering 42.0% off medical cannabis card evaluations and renewals throughout the month of April, our largest ever discount. The promotion is available to both new patients and returning users in participating states via PrestoDoctor’s HIPAA-compliant telemedicine platform. The discount is timed to celebrate 4/20, a widely recognized date in cannabis culture, and reflects the company’s ongoing commitment to affordability, accessibility, and patient wellness. “Our 4/20 promotion is more than a nod to tradition — it’s a way to give back to the community that supports us year-round,” said Rob Tankson, COO of PrestoDoctor....